Clinical Trial

Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation

Name: Workflow Optimization During Pulse Field Ablation for Atrial Fibrillation — clinical trial record (NCT07354217)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Study acronym: PFA_workflow

Not Yet Recruiting Phase 4

View on ClinicalTrials.gov →

Summary

To evaluate the efficacy and safety of intravenous lidocaine in reducing diaphragmatic contraction and suppressing the cough reflex during pulsed field ablation procedures.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-01-14.

Trial Details

NCT Number	NCT07354217
Lead Sponsor	National Taiwan University Hospital Collaborators: Johnson & Johnson
Conditions	Pulsed Field Ablation, Lidocaine
Enrollment	60 participants
Start Date	2026-06-01
Primary Completion	2030-12-31 (estimated)
Study Completion	2030-12-31 (estimated)
Updated on ClinicalTrials.gov	2026-04-20